Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Study
Citation
Jayne , D , Blockmans , D , Luqmani , R , Moiseev , S , Ji , B , Green , Y , Hall , L , Roth , D , Henderson , R B , Merkel , P A & BREVAS Study Collaborators 2019 , ' Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Study ' , Arthritis and Rheumatology , vol. 71 , no. 6 , pp. 952-963 . https://doi.org/10.1002/art.40802
Rights
© 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/